BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29252071)

  • 21. Curcumin specifically binds to the human calcium-calmodulin-dependent protein kinase IV: fluorescence and molecular dynamics simulation studies.
    Hoda N; Naz H; Jameel E; Shandilya A; Dey S; Hassan MI; Ahmad F; Jayaram B
    J Biomol Struct Dyn; 2016; 34(3):572-84. PubMed ID: 25929263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cutting Edge: Nanogel-Based Delivery of an Inhibitor of CaMK4 to CD4+ T Cells Suppresses Experimental Autoimmune Encephalomyelitis and Lupus-like Disease in Mice.
    Otomo K; Koga T; Mizui M; Yoshida N; Kriegel C; Bickerton S; Fahmy TM; Tsokos GC
    J Immunol; 2015 Dec; 195(12):5533-7. PubMed ID: 26561550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arsenic down-regulates the expression of Camk4, an important gene related to cerebellar LTD in mice.
    Wang Y; Li S; Piao F; Hong Y; Liu P; Zhao Y
    Neurotoxicol Teratol; 2009; 31(5):318-22. PubMed ID: 19410645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrantly glycosylated IgG elicits pathogenic signaling in podocytes and signifies lupus nephritis.
    Bhargava R; Lehoux S; Maeda K; Tsokos MG; Krishfield S; Ellezian L; Pollak M; Stillman IE; Cummings RD; Tsokos GC
    JCI Insight; 2021 May; 6(9):. PubMed ID: 33784256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of microRNA-31 as a novel regulator contributing to impaired interleukin-2 production in T cells from patients with systemic lupus erythematosus.
    Fan W; Liang D; Tang Y; Qu B; Cui H; Luo X; Huang X; Chen S; Higgs BW; Jallal B; Yao Y; Harley JB; Shen N
    Arthritis Rheum; 2012 Nov; 64(11):3715-25. PubMed ID: 22736314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CaMK4 is a downstream effector of the α
    Zheng Z; Wang X; Wang Y; King JAC; Xie P; Wu S
    Am J Physiol Cell Physiol; 2021 Dec; 321(6):C964-C977. PubMed ID: 34586897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting lymphocyte signaling pathways as a therapeutic approach to systemic lupus erythematosus.
    Kyttaris VC; Tsokos GC
    Curr Opin Rheumatol; 2011 Sep; 23(5):449-53. PubMed ID: 21720246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-23 reshapes kidney resident cell metabolism and promotes local kidney inflammation.
    Li H; Tsokos MG; Bhargava R; Adamopoulos IE; Menn-Josephy H; Stillman IE; Rosenstiel P; Jordan J; Tsokos GC
    J Clin Invest; 2021 Jun; 131(12):. PubMed ID: 33956666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The dysregulation of cytokine networks in systemic lupus erythematosus.
    Apostolidis SA; Lieberman LA; Kis-Toth K; Crispín JC; Tsokos GC
    J Interferon Cytokine Res; 2011 Oct; 31(10):769-79. PubMed ID: 21877904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcium/calmodulin-dependent protein kinase IV: A multifunctional enzyme and potential therapeutic target.
    Naz H; Islam A; Ahmad F; Hassan MI
    Prog Biophys Mol Biol; 2016 May; 121(1):54-65. PubMed ID: 26773169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pin1-Targeted Therapy for Systemic Lupus Erythematosus.
    Wei S; Yoshida N; Finn G; Kozono S; Nechama M; Kyttaris VC; Zhen Zhou X; Tsokos GC; Ping Lu K
    Arthritis Rheumatol; 2016 Oct; 68(10):2503-13. PubMed ID: 27159270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulated IL-1 Receptor-associated Kinase 1 (IRAK1) in Systemic Lupus Erythematosus: IRAK1 Inhibition Represses Th17 Differentiation with Therapeutic Potential.
    Zhou Z; Tian Z; Zhang M; Zhang Y; Ni B; Hao F
    Immunol Invest; 2018 Jul; 47(5):468-483. PubMed ID: 29611775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-17-producing T cells in lupus.
    Crispín JC; Tsokos GC
    Curr Opin Rheumatol; 2010 Sep; 22(5):499-503. PubMed ID: 20592603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity.
    Moulton VR; Tsokos GC
    J Clin Invest; 2015 Jun; 125(6):2220-7. PubMed ID: 25961450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium/calmodulin dependent protein kinase IV in trophoblast cells under insulin resistance: functional and metabolomic analyses.
    Li L; Li L; Shao Y; Du R; Li L; Shi X; Bai Y
    Mol Med; 2023 Jun; 29(1):82. PubMed ID: 37386367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CAMKK2-CAMK4 signaling regulates transferrin trafficking, turnover, and iron homeostasis.
    Sabbir MG
    Cell Commun Signal; 2020 May; 18(1):80. PubMed ID: 32460794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T lymphocytes in systemic lupus erythematosus: an update.
    Kyttaris VC; Tsokos GC
    Curr Opin Rheumatol; 2004 Sep; 16(5):548-52. PubMed ID: 15314492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spermiogenesis and exchange of basic nuclear proteins are impaired in male germ cells lacking Camk4.
    Wu JY; Ribar TJ; Cummings DE; Burton KA; McKnight GS; Means AR
    Nat Genet; 2000 Aug; 25(4):448-52. PubMed ID: 10932193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The epigenetic face of lupus: Focus on antigen-presenting cells.
    Wardowska A
    Int Immunopharmacol; 2020 Apr; 81():106262. PubMed ID: 32045873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update on the role of autophagy in systemic lupus erythematosus: A novel therapeutic target.
    Pan Q; Gao C; Chen Y; Feng Y; Liu WJ; Liu HF
    Biomed Pharmacother; 2015 Apr; 71():190-3. PubMed ID: 25960235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.